INTRODUCTION
Enteric fever is characterized by systemic illness with fever and abdominal pain 1 .The incidence of enteric fever has declined greatly with the provision of clean water and good sewage systems in Europe and the USA since the early 20 th century 2 but the disease remains a serious publichealth problem in developing countries 3 .Enteric fever is common diagnosis in day to day practice in Kathmandu which can be attributed to poor personal hygiene, poor sanitation, and poor quality of water supply. The treatment of enteric fever at the outset may look straightforward with various classes of effective antibiotics available for use but the emerging resistance is a big problem.
The problem may be choice of too many and choosing appropriate antibiotic can be a challenge at times. Treatment of enteric fever has been complicated by the development and rapid dissemination of typhoidal organisms resistant to ampicillin, trimethoprim-sulfamethoxazole, and chloramphenicol. In recent years, development of resistance to fl uoroquinolones as well as some extent to cephalosporins has resulted in more challenges [4] [5] .
In this setting, it is really challenging to decide which antibiotics to initiate and how long to wait before adding the second drug for the treatment.
In our study, we have tried to fi nd the effi cacy of ofl oxacin and ceftriaxone alone or in combination for the treatment of enteric fever.
METHODS
The randomized clinical study was conducted at Shree Birendra Hospital for a period of one year from January 2011 to July 2011, which comprised of fi fty consecutive patients admitted with clinical diagnosis of Enteric fever as suggested by high grade fever, headache, relative bradycardia, abdominal pain, diarrhoea orconstipation with normal to low leukocyte count. Blood culture was sent from each patient. All patients above 15 years old with the abovementioned clinical features were included in the study and any patient already taking antibiotics from outside setting was excluded. The permission was taken from the hospital administration and consent obtained from the patients. They were randomly divided in two groups to receive either intravenous Ceftriaxone 2 g per day or intravenous ofl oxacin 400 mgper day, which are both, approved fi rst line therapy for enteric fever. Patients were observed for at least fi ve days for the fever defervescence before adding on the second antibiotic (intravenousOfl oxacin in patients receiving Ceftriaxone and intravenous Ceftriaxone in a patients receiving Ofl oxacin). Once the patient became afebrile for about 48 hours they were switched to oral ofl oxacin 800 mg per day or oral Cefi xime 800 mg per day from their respective iv preparations. All patients were planned for total of 14 days of therapy. The patients were discharged after 14 days and asked to follow up after one week in medical OPD.The data were tabulated and analysed using chi-sqaire and t test as indicated using SPSS 17.1 software.
RESULTS
There were 25 patients in Ceftriaxone group and 25 patients in Ofl oxacin group.The baseline characteristics in both the treatment arm were comparable in the study ( Table 1 ).The mean age of the patient in the ofl oxacin group was 28.92 and that of the ceftriaxone grop was 31.36 which was not statistically signifi cant (p=0.45).The distribution of Sex (male), duration of Fever (days), and symptoms like Headache, Abdominal pain, diarrhoea, Constipation, Cough and Blood culture positivity were not different in both the group indicating that both the groups were comparable (Figure 1 ). The fever duration at the time of presentation to hospital for patients in Ceftriaxone group and Ofl oxacin group was 8.6 days and 6.04 days respectively. Six patients in Ceftriaxone group needed addition of Ofl oxacin after fi ve days and two patients in Ofl oxacin group needed addition of Ceftriaxone after fi ve days ( Table 2 ). The average fever defervescence time in Ceftriaxone group was 3.88 days and in Ofl oxacin group was 3.04 days.All patients were afebrile by 9 days of antibiotics. Average duration of hospital stay for patients on Ceftriaxone group was 6.64 days and on Ofl oxacin group was 5.28 days. There were no complications and all patients were discharged from the hospital in stable condition.
DISCUSSION
Enteric fever also known as enteric feveris a systemic illness characterized by high grade fever and abdominal symptoms and it makes a major portion of hospital admission diagnosis for febrile patients in our hospital. Though enteric feveris usually treated with a single antibacterial drug, the optimal choice of drug and duration of therapy is uncertain and the selection of antibiotics depend upon local resistance patterns, patient age, whether oral medications are feasible, the clinical setting, and available resources [6] [7] [8] . The current recommendation for the treatment is with either fl uoroquinolone such as ciprofl oxacin or ofl axacin or with third generationcephalosporins such as ceftraxone 9 . The emergence of multi drug resistance (MDR) strains have caused numerous outbreaks in the Indian subcontinent, Southeast Asia, Mexico, the Arabian Gulf, and Africa 4,10. There are concerns with the resistance even with ofl oxacin and ceftriaxone [4] [5] . In this study, we tried to see the response of enteric fever in terms of fever defervescene with Ofl oxacin, Cefriaxone or both.
The common presenting symptoms of enteric fever which are fever, abdominal pain, headache, cough, diarrhea and constipation were consistent with other previous studies. In a study conducted by David et al 11 in CIWEC clinic of Nepal and by Sharma et al 12 in Dhulikhel have shown the similar clinical features of typhoid fever.
In view of poor result from the blood culture, which was only 5 % of total cases, we had to depend mostly on the clinical features of typhoid fever. The low yield of culture may be due to inappropriate use of antibiotics by the primary care health worker before the patient presents to the hospital and the delay in incubating the media after the blood withdrawal. 
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The average fever defervescence time in Ceftriaxone group was 3.88 days and in Ofl oxacin group was 3.04 days which was also consistent with the similar studies of enteric fever done in Kathmandu 12 . In our study, six of the patients receiving ceftriaxone and two of those receiving ofl oxacin needed the addition of the second drug which was ofl oxacin in ceftriaxone group and vice versa. The study done by Sharma et al 12 in Dhulikhel hospital had shown 100% sensitivity to the ceftriaxone however the present fi nding of our study showed different result. Smith et al had shown in his study when comparing the treatment with oral ofl oxacin with intravenous ceftriaxone in Vietnamese patients, that short-course treatment with oral ofl oxacin was signifi cantly better than that withceftriaxone 13 .
The low number of sample size and the lack of correlation whether the non responder were having resistant to the treatment drug in vitro also have been the limitation of our study. However it does provide a new area of research for the emerging resistance pattern of the salmonella species in our part of the world. It also raises the concern whether multi drug therapy may be better than monotherapy in order to avoid treatment failure or drug resistance.
CONCLUSION
Fever defervescence time with Ofl oxacin was lesser than ceftriaxone group and need of supplementary antibiotic is lesser in ofl oxacine group. So, ofl oxacin can be recommended as 1 st line drug for enteric fever. Further large randomised trials are needed to substantiate the fi ndings. 
